99 related articles for article (PubMed ID: 1632976)
1. Serum tumour necrosis factor alpha levels in benign and malignant lesions of the endometrium in postmenopausal women. A preliminary study.
Shaarawy M; Abdel-Aziz O
Acta Oncol; 1992; 31(4):417-20. PubMed ID: 1632976
[TBL] [Abstract][Full Text] [Related]
2. [The role of prolactin in endometrial lesions].
Tolino A; Di Serio C; Caracciolo GB; Tartaglia E; Riccio S
Minerva Ginecol; 1991 Nov; 43(11):495-7. PubMed ID: 1784404
[TBL] [Abstract][Full Text] [Related]
3. Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium.
Scirpa P; Mango D; Battaglia F; Scirpa S; Montemurro A
Maturitas; 1982 Apr; 4(1):33-42. PubMed ID: 7099001
[TBL] [Abstract][Full Text] [Related]
4. Differences in serum bisphenol a concentrations in premenopausal normal women and women with endometrial hyperplasia.
Hiroi H; Tsutsumi O; Takeuchi T; Momoeda M; Ikezuki Y; Okamura A; Yokota H; Taketani Y
Endocr J; 2004 Dec; 51(6):595-600. PubMed ID: 15644579
[TBL] [Abstract][Full Text] [Related]
5. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
[TBL] [Abstract][Full Text] [Related]
6. Superoxide dismutase and lipid hydroperoxides in blood and endometrial tissue of patients with benign, hyperplastic and malignant endometrium.
Pejić S; Todorović A; Stojiljković V; Cvetković D; Lucić N; Radojicić RM; Saicić ZS; Pajović SB
An Acad Bras Cienc; 2008 Sep; 80(3):515-22. PubMed ID: 18797802
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal endometrial patterns and serum estradiol concentrations.
Ismail AA; Ramadan M; Soliman A; Rahmy A; Rizk A
Int J Gynaecol Obstet; 1988 Aug; 27(1):101-5. PubMed ID: 2905283
[TBL] [Abstract][Full Text] [Related]
8. Leptin levels in serum depending on Body Mass Index in patients with endometrial hyperplasia and cancer.
Cymbaluk A; Chudecka-Głaz A; Rzepka-Górska I
Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):74-7. PubMed ID: 17007993
[TBL] [Abstract][Full Text] [Related]
9. Potential of the learning vector quantizer in the cell classification of endometrial lesions in postmenopausal women.
Karakitsos P; Kyroudes A; Pouliakis A; Stergiou EB; Voulgaris Z; Kittas C
Anal Quant Cytol Histol; 2002 Feb; 24(1):30-8. PubMed ID: 11865947
[TBL] [Abstract][Full Text] [Related]
10. Predictive Value of Hematological Inflammatory Markers in Endometrial Neoplasia.
Bacanakgil BH; Kaban I; Unal F; Guven R; Sahin E; Yildirim SG
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1529-1532. PubMed ID: 29936727
[TBL] [Abstract][Full Text] [Related]
11. Progesterone challenge test and estrogen assays in menopausal women with endometrial adenomatous hyperplasia.
Toppozada MK; Ismail AA; Hamed RS; Ahmed KS; el-Faras A
Int J Gynaecol Obstet; 1988 Feb; 26(1):115-9. PubMed ID: 2892727
[TBL] [Abstract][Full Text] [Related]
12. [Serum E2 and progesterone levels in patients with atypical hyperplasia and endometrial carcinoma].
Gorchev G; Maleeva A
Akush Ginekol (Sofiia); 1993; 32(2):23-4. PubMed ID: 8010393
[TBL] [Abstract][Full Text] [Related]
13. Investigations for postmenopausal uterine bleeding: special considerations for endometrial volume.
Cho HJ; Lee ES; Lee JY; Hong SN; Ji YI; Kim HY; Kim A
Arch Iran Med; 2013 Nov; 16(11):665-70. PubMed ID: 24206410
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of tumor necrosis factor in squamous cell carcinoma of the head and neck.
Soylu L; Ozcan C; Cetik F; Paydaş S; Kiroğlu M; Aydoğan B; Sargin O; Ozşahinoglu C; Seyrek E
Am J Otolaryngol; 1994; 15(4):281-5. PubMed ID: 7978027
[TBL] [Abstract][Full Text] [Related]
15. [Differential diagnosis of endometrial abnormality by transvaginal sonography].
Gu CX; He FF; Xiang H
Zhonghua Fu Chan Ke Za Zhi; 1994 Dec; 29(12):720-3, 761. PubMed ID: 7712899
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
[TBL] [Abstract][Full Text] [Related]
17. [Structural chromosome aberrations in the peripheral blood lymphocytes in patients with precancer and endometrial cancer].
Polishchuk LZ; Nesina IP
Tsitol Genet; 1995; 29(3):17-24. PubMed ID: 7676506
[TBL] [Abstract][Full Text] [Related]
18. Thickened endometrium in the postmenopausal woman: sonographic-pathologic correlation.
Sheth S; Hamper UM; Kurman RJ
Radiology; 1993 Apr; 187(1):135-9. PubMed ID: 8451399
[TBL] [Abstract][Full Text] [Related]
19. Microvessel density assessment in benign and malignant endometrial changes.
Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
[TBL] [Abstract][Full Text] [Related]
20. [Use of hysteroscopy, ultrasonography and selected hormonal tests for diagnosis of hyperplastic endometrial changes].
Bedner R
Ann Acad Med Stetin; 2001; 47():89-105. PubMed ID: 12514904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
